Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting

Bum Joon Kim, Joo Y. Kwon, Jin-Man Jung, Deok Hee Lee, Dong Wha Kang, Jong S. Kim, Sun U. Kwon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Object. Endovascular procedures are one of the important treatment options for steno-occlusive arteries in ischemic stroke patients. However, embolic complications after such procedures are always a concern. The authors investigated the association between serial change of residual platelet reactivity and silent embolic cerebral infarction (SECI) after endovascular treatment.

Methods. Ischemic stroke patients undergoing stenting of intra- or extracranial arteries were recruited prospectively. Residual platelet reactivity, represented by aspirin reaction units (ARUs) and P2Y12 reaction units (PRUs), was measured serially (6 hours before, immediately after, and 24 hours after the procedure). A loading dosage of aspirin (500 mg) and/or clopidogrel (300 mg) was given 24 hours before the procedure to patients naïve to antiplatelet agents, whereas the usual dosage (aspirin 100 mg and clopidogrel 75 mg) was continued for patients who had previously been taking these agents for more than a week. Diffusion-weighted MRI was performed before and 24 hours after the procedure to detect new SECIs. Clinical characteristics, baseline ARU and PRU values, and the change in ARU and PRU values after stenting were compared between patients with and without SECIs.

Results. Among 69 consecutive patients who underwent neurovascular stent insertion, 41 patients (59.4%) had poststenting SECIs. The lesion was located only at the vascular territory of the stented vessel in 21 patients (51.2%), outside the stented vessel territory in 8 patients (19.5%), and both inside and outside in 12 patients (29.3%). The occurrence of SECIs was not associated with the baseline ARU or PRU value, but was associated with PRU increase after stenting (36 ± 73 vs -12 ± 59, p = 0.007), deployment of a longer stent (31.1 ± 16.5 mm vs 21.8 ± 9.9 mm, p = 0.01), and stent insertion in extracranial arteries (78.1% vs 45.2%, p = 0.008). Stent length (OR 1.066, p = 0.01) and PRU change (OR 1.009, p = 0.04) were independently associated with the occurrence of SECI.

Conclusions. Residual platelet reactivity after dual antiplatelet treatment measured before stenting did not predict poststenting SECI. However, the longer stent and the serial increase of PRU values after stenting were related to SECI. Continuous increase of platelet activation after endovascular procedure may be important in poststent cerebral infarction.

Original languageEnglish
Pages (from-to)891-898
Number of pages8
JournalJournal of Neurosurgery
Volume121
Issue number4
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Cerebral Infarction
Aspirin
clopidogrel
Stents
Endovascular Procedures
Blood Platelets
Arteries
Stroke
Diffusion Magnetic Resonance Imaging
Platelet Aggregation Inhibitors
Platelet Activation
Blood Vessels
Therapeutics

Keywords

  • Embolic infarction
  • Neurovascular stenting
  • Residual platelet reactivity
  • Vascular disorders

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting. / Kim, Bum Joon; Kwon, Joo Y.; Jung, Jin-Man; Lee, Deok Hee; Kang, Dong Wha; Kim, Jong S.; Kwon, Sun U.

In: Journal of Neurosurgery, Vol. 121, No. 4, 01.01.2014, p. 891-898.

Research output: Contribution to journalArticle

Kim, Bum Joon ; Kwon, Joo Y. ; Jung, Jin-Man ; Lee, Deok Hee ; Kang, Dong Wha ; Kim, Jong S. ; Kwon, Sun U. / Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting. In: Journal of Neurosurgery. 2014 ; Vol. 121, No. 4. pp. 891-898.
@article{a49ef7cf5e214ff0bad806c946e50e51,
title = "Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting",
abstract = "Object. Endovascular procedures are one of the important treatment options for steno-occlusive arteries in ischemic stroke patients. However, embolic complications after such procedures are always a concern. The authors investigated the association between serial change of residual platelet reactivity and silent embolic cerebral infarction (SECI) after endovascular treatment.Methods. Ischemic stroke patients undergoing stenting of intra- or extracranial arteries were recruited prospectively. Residual platelet reactivity, represented by aspirin reaction units (ARUs) and P2Y12 reaction units (PRUs), was measured serially (6 hours before, immediately after, and 24 hours after the procedure). A loading dosage of aspirin (500 mg) and/or clopidogrel (300 mg) was given 24 hours before the procedure to patients na{\"i}ve to antiplatelet agents, whereas the usual dosage (aspirin 100 mg and clopidogrel 75 mg) was continued for patients who had previously been taking these agents for more than a week. Diffusion-weighted MRI was performed before and 24 hours after the procedure to detect new SECIs. Clinical characteristics, baseline ARU and PRU values, and the change in ARU and PRU values after stenting were compared between patients with and without SECIs.Results. Among 69 consecutive patients who underwent neurovascular stent insertion, 41 patients (59.4{\%}) had poststenting SECIs. The lesion was located only at the vascular territory of the stented vessel in 21 patients (51.2{\%}), outside the stented vessel territory in 8 patients (19.5{\%}), and both inside and outside in 12 patients (29.3{\%}). The occurrence of SECIs was not associated with the baseline ARU or PRU value, but was associated with PRU increase after stenting (36 ± 73 vs -12 ± 59, p = 0.007), deployment of a longer stent (31.1 ± 16.5 mm vs 21.8 ± 9.9 mm, p = 0.01), and stent insertion in extracranial arteries (78.1{\%} vs 45.2{\%}, p = 0.008). Stent length (OR 1.066, p = 0.01) and PRU change (OR 1.009, p = 0.04) were independently associated with the occurrence of SECI.Conclusions. Residual platelet reactivity after dual antiplatelet treatment measured before stenting did not predict poststenting SECI. However, the longer stent and the serial increase of PRU values after stenting were related to SECI. Continuous increase of platelet activation after endovascular procedure may be important in poststent cerebral infarction.",
keywords = "Embolic infarction, Neurovascular stenting, Residual platelet reactivity, Vascular disorders",
author = "Kim, {Bum Joon} and Kwon, {Joo Y.} and Jin-Man Jung and Lee, {Deok Hee} and Kang, {Dong Wha} and Kim, {Jong S.} and Kwon, {Sun U.}",
year = "2014",
month = "1",
day = "1",
doi = "10.3171/2014.6.JNS132448",
language = "English",
volume = "121",
pages = "891--898",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "4",

}

TY - JOUR

T1 - Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting

AU - Kim, Bum Joon

AU - Kwon, Joo Y.

AU - Jung, Jin-Man

AU - Lee, Deok Hee

AU - Kang, Dong Wha

AU - Kim, Jong S.

AU - Kwon, Sun U.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Object. Endovascular procedures are one of the important treatment options for steno-occlusive arteries in ischemic stroke patients. However, embolic complications after such procedures are always a concern. The authors investigated the association between serial change of residual platelet reactivity and silent embolic cerebral infarction (SECI) after endovascular treatment.Methods. Ischemic stroke patients undergoing stenting of intra- or extracranial arteries were recruited prospectively. Residual platelet reactivity, represented by aspirin reaction units (ARUs) and P2Y12 reaction units (PRUs), was measured serially (6 hours before, immediately after, and 24 hours after the procedure). A loading dosage of aspirin (500 mg) and/or clopidogrel (300 mg) was given 24 hours before the procedure to patients naïve to antiplatelet agents, whereas the usual dosage (aspirin 100 mg and clopidogrel 75 mg) was continued for patients who had previously been taking these agents for more than a week. Diffusion-weighted MRI was performed before and 24 hours after the procedure to detect new SECIs. Clinical characteristics, baseline ARU and PRU values, and the change in ARU and PRU values after stenting were compared between patients with and without SECIs.Results. Among 69 consecutive patients who underwent neurovascular stent insertion, 41 patients (59.4%) had poststenting SECIs. The lesion was located only at the vascular territory of the stented vessel in 21 patients (51.2%), outside the stented vessel territory in 8 patients (19.5%), and both inside and outside in 12 patients (29.3%). The occurrence of SECIs was not associated with the baseline ARU or PRU value, but was associated with PRU increase after stenting (36 ± 73 vs -12 ± 59, p = 0.007), deployment of a longer stent (31.1 ± 16.5 mm vs 21.8 ± 9.9 mm, p = 0.01), and stent insertion in extracranial arteries (78.1% vs 45.2%, p = 0.008). Stent length (OR 1.066, p = 0.01) and PRU change (OR 1.009, p = 0.04) were independently associated with the occurrence of SECI.Conclusions. Residual platelet reactivity after dual antiplatelet treatment measured before stenting did not predict poststenting SECI. However, the longer stent and the serial increase of PRU values after stenting were related to SECI. Continuous increase of platelet activation after endovascular procedure may be important in poststent cerebral infarction.

AB - Object. Endovascular procedures are one of the important treatment options for steno-occlusive arteries in ischemic stroke patients. However, embolic complications after such procedures are always a concern. The authors investigated the association between serial change of residual platelet reactivity and silent embolic cerebral infarction (SECI) after endovascular treatment.Methods. Ischemic stroke patients undergoing stenting of intra- or extracranial arteries were recruited prospectively. Residual platelet reactivity, represented by aspirin reaction units (ARUs) and P2Y12 reaction units (PRUs), was measured serially (6 hours before, immediately after, and 24 hours after the procedure). A loading dosage of aspirin (500 mg) and/or clopidogrel (300 mg) was given 24 hours before the procedure to patients naïve to antiplatelet agents, whereas the usual dosage (aspirin 100 mg and clopidogrel 75 mg) was continued for patients who had previously been taking these agents for more than a week. Diffusion-weighted MRI was performed before and 24 hours after the procedure to detect new SECIs. Clinical characteristics, baseline ARU and PRU values, and the change in ARU and PRU values after stenting were compared between patients with and without SECIs.Results. Among 69 consecutive patients who underwent neurovascular stent insertion, 41 patients (59.4%) had poststenting SECIs. The lesion was located only at the vascular territory of the stented vessel in 21 patients (51.2%), outside the stented vessel territory in 8 patients (19.5%), and both inside and outside in 12 patients (29.3%). The occurrence of SECIs was not associated with the baseline ARU or PRU value, but was associated with PRU increase after stenting (36 ± 73 vs -12 ± 59, p = 0.007), deployment of a longer stent (31.1 ± 16.5 mm vs 21.8 ± 9.9 mm, p = 0.01), and stent insertion in extracranial arteries (78.1% vs 45.2%, p = 0.008). Stent length (OR 1.066, p = 0.01) and PRU change (OR 1.009, p = 0.04) were independently associated with the occurrence of SECI.Conclusions. Residual platelet reactivity after dual antiplatelet treatment measured before stenting did not predict poststenting SECI. However, the longer stent and the serial increase of PRU values after stenting were related to SECI. Continuous increase of platelet activation after endovascular procedure may be important in poststent cerebral infarction.

KW - Embolic infarction

KW - Neurovascular stenting

KW - Residual platelet reactivity

KW - Vascular disorders

UR - http://www.scopus.com/inward/record.url?scp=84907874928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907874928&partnerID=8YFLogxK

U2 - 10.3171/2014.6.JNS132448

DO - 10.3171/2014.6.JNS132448

M3 - Article

C2 - 25036195

AN - SCOPUS:84907874928

VL - 121

SP - 891

EP - 898

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 4

ER -